Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease

医学 传统PCI 经皮冠状动脉介入治疗 入射(几何) 左主干冠状动脉疾病 冠状动脉疾病 血运重建 心脏病学 累积发病率 内科学 比例危险模型 旁路移植 冠状动脉搭桥手术 动脉 心肌梗塞 队列 光学 物理
作者
Ioanna Kosmidou,Bahira Shahim,Ovidiu Dressler,Björn Redfors,Marie‐Claude Morice,John D. Puskas,David E. Kandzari,Dimitri Karmpaliotis,W. Morris Brown,Nicholas Lembo,Adrian Banning,A. Pieter Kappetein,Patrick W. Serruys,Joseph F. Sabik,Gregg W. Stone
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:83 (11): 1073-1081 被引量:4
标识
DOI:10.1016/j.jacc.2024.01.012
摘要

The frequency of and relationship between hospital readmissions and outcomes after revascularization for left main coronary artery disease (LMCAD) are unknown. The purpose of this study was to study the incidence, predictors, and clinical impact of readmissions following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for LMCAD. In the EXCEL (XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, 1,905 patients with LMCAD were randomized to PCI vs CABG. The cumulative incidence of readmissions was analyzed with multivariable Anderson-Gill and joint frailty models to account for recurrent events and the competing risk of death. The impact of readmission on subsequent mortality within 5-year follow-up was determined in a time-adjusted Cox proportional hazards model. Within 5 years, 1,868 readmissions occurred in 851 of 1,882 (45.2%) hospital survivors (2.2 ± 1.9 per patient with readmission[s], range 1-16), approximately one-half for cardiovascular causes and one-half for noncardiovascular causes (927 [49.6%] and 941 [50.4%], respectively). One or more readmissions occurred in 463 of 942 (48.6%) PCI patients vs 388 of 940 (41.8%) CABG patients (P = 0.003). After multivariable adjustment, PCI remained an independent predictor of readmission (adjusted HR: 1.22; 95% CI: 1.10-1.35; P < 0.0001), along with female sex, comorbidities, and the extent of CAD. Readmission was independently associated with subsequent all-cause death, with interaction testing indicating a higher risk after PCI than CABG (adjusted HR: 5.72; 95% CI: 3.42-9.55 vs adjusted HR: 2.72; 95% CI: 1.64-4.88, respectively; Pint = 0.03). In the EXCEL trial, readmissions during 5-year follow-up after revascularization for LMCAD were common and more frequent after PCI than CABG. Readmissions were associated with an increased risk of all-cause death, more so after PCI than with CABG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
世间安得双全法完成签到,获得积分0
2秒前
Xenia完成签到 ,获得积分10
3秒前
小胖完成签到 ,获得积分10
4秒前
豆花浮元子完成签到 ,获得积分10
5秒前
修语完成签到,获得积分10
5秒前
aDou完成签到 ,获得积分10
6秒前
菓小柒完成签到 ,获得积分10
8秒前
xc完成签到 ,获得积分10
10秒前
i2stay完成签到,获得积分10
10秒前
随心所欲完成签到 ,获得积分10
15秒前
panda完成签到,获得积分10
15秒前
吃饱再睡完成签到 ,获得积分10
15秒前
星辰大海应助Wang采纳,获得10
18秒前
沙漠西瓜皮完成签到 ,获得积分10
19秒前
19秒前
法桐落梦发布了新的文献求助100
22秒前
为你钟情完成签到 ,获得积分10
22秒前
sougardenist完成签到 ,获得积分10
23秒前
27秒前
量子星尘发布了新的文献求助10
29秒前
30秒前
栀子红了完成签到 ,获得积分10
31秒前
仁爱的觅夏完成签到,获得积分10
31秒前
SY15732023811完成签到 ,获得积分10
32秒前
小粒橙完成签到 ,获得积分10
38秒前
自觉柠檬完成签到 ,获得积分10
39秒前
lkk完成签到,获得积分10
41秒前
无辜妙海完成签到,获得积分10
41秒前
SciEngineerX完成签到,获得积分10
42秒前
活力书包完成签到 ,获得积分10
45秒前
法桐落梦完成签到,获得积分10
49秒前
四十四次日落完成签到 ,获得积分10
52秒前
tmobiusx完成签到,获得积分10
53秒前
wmc1357完成签到,获得积分10
58秒前
LILYpig完成签到 ,获得积分10
1分钟前
大气夜山完成签到 ,获得积分10
1分钟前
1分钟前
一枝完成签到 ,获得积分10
1分钟前
Jason完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
A new approach to the extrapolation of accelerated life test data 1000
Coking simulation aids on-stream time 450
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
Novel Preparation of Chitin Nanocrystals by H2SO4 and H3PO4 Hydrolysis Followed by High-Pressure Water Jet Treatments 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4015603
求助须知:如何正确求助?哪些是违规求助? 3555597
关于积分的说明 11318138
捐赠科研通 3288782
什么是DOI,文献DOI怎么找? 1812284
邀请新用户注册赠送积分活动 887882
科研通“疑难数据库(出版商)”最低求助积分说明 812015